EPH21 Real-world evidence of adverse kidney outcomes for intravitreal use of vascular endothelial growth factor (VEGF) inhibitors among patients with diabetic retinopathy

Objective: Studies of kidney injury following use of intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections among patients with diabetic retinopathy have mixed results and are limited by sample size and study design. Our objective was to determine whether intravitreal use of ant...

Full description

Autores:

Chen, NC
Kane-Gill, S
Suh, K

Tipo de recurso:

Article of investigation

Fecha de publicación:

2022

Institución:

Corporación Universidad de la Costa

Repositorio:

REDICUC - Repositorio CUC

Idioma:

eng

OAI Identifier:

oai:repositorio.cuc.edu.co:11323/10722

Acceso en línea:

https://hdl.handle.net/11323/10722
https://repositorio.cuc.edu.co/

Palabra clave:

Diabetic retinopathy
Vascular Endothelial Growth Factor (VEGF)
Kidney

Rights

embargoedAccess

License

Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)